HTG Molecular Diagnostics (HTGM) Tops Q3 EPS by 9c

HTG Molecular Diagnostics (NASDAQ: HTGM) reported Q3 EPS of ($0.76), $0.09 better than the analyst estimate of ($0.85). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.07 million.

For earnings history and earnings-related data on HTG Molecular Diagnostics (HTGM) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings